Projected Price to Earnings: Aethlon (AEMD)
Aethlon Medical (AEMD) relies on external financing, as its primary developments are undergoing clinical validation without a stable cash flow. Aethlon Medical creates defensive solutions in collaboration with state defense orders and specialized centers. The developer of Hemopurifier is patenting methods for blood purification from exosomes in oncology. The company's forward P/E ratio reflects market expectations, with the current value equal to 0.00.
Metric breakdowns and analytics for Aethlon Medical Corp (AEMD)
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- company liabilities and liquidity data:
Total Debt to Capital Aethlon Medical|AEMD - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Aethlon Medical|AEMD - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Aethlon Medical Inc|AEMD - Company Long-Term Liabilities|Company Short-Term Debts Aethlon Medical|Quick Ratio aethlonmedical.com
- financial results and valuation multiples details:
AEMD - Company Profit|Projected Future Earnings Aethlon Medical|AEMD - Business Payback Period|Forward P/E Multiple Aethlon|AEMD - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Aethlon Medical Inc|AEMD - Operating profit EBITDA|Earnings per share for the last twelve months Aethlon Medical|AEMD - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months aethlonmedical.com|AEMD - Earnings per share increase in current year|Earnings growth forecast for next year Aethlon Medical
- company sales and revenue statistics:
Fundamental valuation:AEMD Aethlon Medical, Inc.
The forward P/E reflects market expectations by comparing the current share price with projected future net income to assess the premium paid for future earnings. For Aethlon Medical (AEMD), which is burning capital on clinical trials without generating sales, the company's expected P/E level demonstrates the highly speculative nature of the assets in the complete absence of operating cash flow.
Competitors of Aethlon Medical
Forward P/E Multiple DXCM|PEN - Projected Price to Earnings Ratio|Novanta Corp - Projected Price to Earnings|Forward P/E Multiple Haemonetics Company HAE|INSP: Projected Price to Earnings|procept-biorobotics.com - Market Cap to Future Earnings Ratio|CNMD: Forward P/E Multiple|PLSE - Market Cap to Projected Earnings|INMD (InMode Corp) - Forward P/E Multiple|Projected Price to Earnings Picard Group (PMI)|Projected Price to Earnings SRDX (Surmodics, Inc.)|SENS (Senseonics Holdings, Inc.) - Future Price to Earnings Multiple|Future Price to Earnings NeuroPace NPCE|TCMD - Projected Price to Earnings|SANUWAVE Health, Inc. - Forward P/E Multiple|Projected Price to Earnings Ratio Outset Medical Corp|ELMD: Forward P/E Multiple|Price to Future Earnings Ratio LNSR|RCEL (AVITA Medical) - Forward P/E Multiple|Profound Medical Corporation (PROF) - Market Cap to Projected Earnings|Forward P/E Multiple BDMD|Projected Price to Earnings edap-tms.com EDAP|Forward P/E Multiple APYX (Apyx Medical Corporation)|Forward P/E Multiple IceCure Medical Ltd. ICCM|LUNG - Future Price to Earnings|TELA: Future Price to Earnings|CTSO (cytosorbents.com) - Projected Price to Earnings|Sensus - Future Price to Earnings Multiple|ZYXI (Zynex, Inc.) - Forward P/E Multiple|Projected Price to Earnings Ratio electroCore Medical ECOR|Future Price to Earnings Vicarious Surgical Inc. (RBOT)|inspira-technologies.com (IINN) - Forward Price to Earnings Multiple|SeaStar Medical Holding Corp - Projected Price to Earnings|Forward P/E Multiple IRIDEX Corp IRIX|Intelligent Bio - Forward P/E Multiple|Market Cap to Projected Earnings Beyond Air, Inc. XAIR|Profusa (PFSA) - Future Price to Earnings|Price to Expected Earnings Ratio SSKN (STRATA Skin Sciences, Inc.)|Future Price to Earnings GlucoTrack|Projected Price to Earnings NanoVibronix Inc. (NAOV)|Forward P/E Multiple VERO|NUWE - Projected Price to Earnings Ratio|Future Price to Earnings Asensus Surgical ASXC|AVGR: Price to Future Earnings Ratio|BSGM: Projected Price to Earnings|Cutera Inc - Market Cap to Future Earnings Ratio|KNW: Forward P/E Multiple|inarimedical.com (NARI) - Forward P/E Multiple|NVRO (Nevro) - Forward P/E Multiple|Projected Price to Earnings Ratio ReShape Lifesciences Inc RSLS|Projected Price to Earnings SILK (Silk Road Medical Inc.)
